Datacentre developer secures long-term deal with major US customer for 555MW of capacity.
NZX-listed software-as-a-service business implements cost-cutting measures as losses mount.
The wellness retailer says outlook remains "challenging" following tough year.
Full-year profit rises to $95.9 million, while net interest margin fell to 3.97%.
Five years after listing across the Tasman as Keytone Enterprises, trading in its shares is suspended with the appointment of receivers.
CEO Grant Webster exceptionally pleased with result but warns markets like North America are heading into softer territory.
The listed health company does not expect a material effect on 2024 earnings guidance.
The NZX-listed publican is set to delist later this year, if shareholders approve the sale of its business.
Gentailer touts 4.7GW pipeline of renewable energy development.
Chemicals group’s only female director has resigned.
